business
Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline
Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline
Read full story on Yahoo Finance → More top storiesAlso covered by
ARY News
Greggs’ new menu helps bake in sales growth, shares rise
Investing.com
Earnings call transcript: Verrica Pharmaceuticals Q1 2026 shows revenue growth
Investing.com
Earnings call transcript: Phoenix New Media sees strong Q1 2026 revenue growth
Investing.com
Earnings call transcript: Radius Care’s FY 2026 robust growth and stock rise
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop